Filing Details

Accession Number:
0001203311-22-000053
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-17 21:14:26
Reporting Period:
2022-08-15
Accepted Time:
2022-08-17 21:14:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1060736 Seagen Inc. SGEN Biological Products, (No Disgnostic Substances) (2836) 911874389
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1241357 I Jean Liu 21823 30Th Drive Se
Bothell WA 98021
Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-15 13,731 $0.00 89,677 No 4 A Direct
Common Stock Disposition 2022-08-16 922 $170.22 88,755 No 4 S Direct
Common Stock Disposition 2022-08-16 717 $170.22 88,038 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. These shares represent restricted stock units and will be settled in common stock upon vesting.
  2. Shares shall vest at a rate of 25% on each anniversary of August 15, 2022 until all shares are fully vested at the end of four years.
  3. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
  4. Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.